The Asia Pacific Cluster Headache Market would witness market growth of 4.8% CAGR during the forecast period (2022-2028).
Periodic headache-causing triggers include the brain's blood vessels shifting in response to headaches. People become more susceptible to nicotine and alcohol due to these changes. Even a small amount of alcohol consumption might cause headaches. Smoking can also exacerbate headaches or even cause them. Just on the side of the headache the nose starts to flow or get stuffy. Eye issues include eye discomfort, watery eyes, and drooping eyelids. The patient’s pupil, which is the dark spot in the middle of the eye, could also appear smaller. On the headache side, patients can start sweating, and their face might get flushed.
Even though cluster headaches are incurable, some treatments might lessen their discomfort. Abortive care to halt attacks: A headache frequently ends before the patient can consult a doctor. Yet, several efficient techniques exist to stop a cluster headache if the patient acts quickly. One could receive a nasal spray or an injection of medicine from a medical professional. Sumatriptan, dihydroergotamine, and zolmitriptan are a few of them. They could also receive oxygen from the supplier via a mask.
The pharmaceutical sector in India is worth $50 billion. 3.5% of all medications and medicines shipped internationally to more than 200 nations come from this nation. The Department of Pharmaceuticals has introduced three supporting programs to encourage international and domestic players to increase investment and production in these product categories to ensure greater resilience to external shocks, enforce greater drug security, and increase domestic production capacity for critical bulk drugs high-value products alike. The Schemes are intended to increase the Indian pharmaceutical industry's resilience to external shocks and significantly advance the achievement of a higher goal of sustainable access to inexpensive healthcare domestically and abroad. This supports the growth of the regional market.
The China market dominated the Asia Pacific Cluster Headache Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $34.5 Million by 2028. The Japan market is estimated to grow a CAGR of 4.2% during (2022 - 2028). Additionally, The India market would display a CAGR of 5.4% during (2022 - 2028).
Based on Distribution channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Others. Based on Type, the market is segmented Episodic, and Chronic. Based on Drug Class, the market is segmented into Triptans, Calcium Channel Blockers, Ergot Derivatives, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Cluster Headache Market is Projected to reach USD 437.5 Million by 2028, at a CAGR of 4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Dr. Reddy’s Laboratories Ltd., Novartis AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline PLC (GSK), Pfizer, Inc., Fresenius SE & Co. KGaA, Eli Lilly And Company, Grünenthal GmbH, and Arrotex Pharmaceuticals Pty Limited.
Scope of the Study
Market Segments Covered in the Report:
By Distribution channel
- Drug Stores & Retail Pharmacies
- Hospital Pharmacies
- Others
By Type
By Drug Class
- Triptans
- Calcium Channel Blockers
- Ergot Derivatives
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Dr.Reddy’s Laboratories Ltd.
- Novartis AG
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- GlaxoSmithKline PLC (GSK)
- Pfizer, Inc.
- Fresenius SE & Co. KGaA
- Eli Lilly And Company
- Grünenthal GmbH
- Arrotex Pharmaceuticals Pty Limited
TABLE 1 Asia Pacific Cluster Headache Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Cluster Headache Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Cluster Headache Market by Type, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Cluster Headache Market by Type, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Episodic Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Episodic Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Chronic Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Chronic Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Triptans Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Triptans Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Calcium Channel Blockers Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Calcium Channel Blockers Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Ergot Derivatives Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Ergot Derivatives Market by Country, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Cluster Headache Market by Country, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Cluster Headache Market by Country, 2022 - 2028, USD Million
TABLE 29 China Cluster Headache Market, 2018 - 2021, USD Million
TABLE 30 China Cluster Headache Market, 2022 - 2028, USD Million
TABLE 31 China Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
TABLE 32 China Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
TABLE 33 China Cluster Headache Market by Type, 2018 - 2021, USD Million
TABLE 34 China Cluster Headache Market by Type, 2022 - 2028, USD Million
TABLE 35 China Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
TABLE 36 China Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
TABLE 37 Japan Cluster Headache Market, 2018 - 2021, USD Million
TABLE 38 Japan Cluster Headache Market, 2022 - 2028, USD Million
TABLE 39 Japan Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
TABLE 40 Japan Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
TABLE 41 Japan Cluster Headache Market by Type, 2018 - 2021, USD Million
TABLE 42 Japan Cluster Headache Market by Type, 2022 - 2028, USD Million
TABLE 43 Japan Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
TABLE 44 Japan Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
TABLE 45 India Cluster Headache Market, 2018 - 2021, USD Million
TABLE 46 India Cluster Headache Market, 2022 - 2028, USD Million
TABLE 47 India Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
TABLE 48 India Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
TABLE 49 India Cluster Headache Market by Type, 2018 - 2021, USD Million
TABLE 50 India Cluster Headache Market by Type, 2022 - 2028, USD Million
TABLE 51 India Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
TABLE 52 India Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
TABLE 53 South Korea Cluster Headache Market, 2018 - 2021, USD Million
TABLE 54 South Korea Cluster Headache Market, 2022 - 2028, USD Million
TABLE 55 South Korea Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
TABLE 56 South Korea Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
TABLE 57 South Korea Cluster Headache Market by Type, 2018 - 2021, USD Million
TABLE 58 South Korea Cluster Headache Market by Type, 2022 - 2028, USD Million
TABLE 59 South Korea Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
TABLE 60 South Korea Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
TABLE 61 Singapore Cluster Headache Market, 2018 - 2021, USD Million
TABLE 62 Singapore Cluster Headache Market, 2022 - 2028, USD Million
TABLE 63 Singapore Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
TABLE 64 Singapore Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
TABLE 65 Singapore Cluster Headache Market by Type, 2018 - 2021, USD Million
TABLE 66 Singapore Cluster Headache Market by Type, 2022 - 2028, USD Million
TABLE 67 Singapore Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
TABLE 68 Singapore Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
TABLE 69 Malaysia Cluster Headache Market, 2018 - 2021, USD Million
TABLE 70 Malaysia Cluster Headache Market, 2022 - 2028, USD Million
TABLE 71 Malaysia Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
TABLE 72 Malaysia Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
TABLE 73 Malaysia Cluster Headache Market by Type, 2018 - 2021, USD Million
TABLE 74 Malaysia Cluster Headache Market by Type, 2022 - 2028, USD Million
TABLE 75 Malaysia Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
TABLE 76 Malaysia Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
TABLE 77 Rest of Asia Pacific Cluster Headache Market, 2018 - 2021, USD Million
TABLE 78 Rest of Asia Pacific Cluster Headache Market, 2022 - 2028, USD Million
TABLE 79 Rest of Asia Pacific Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
TABLE 80 Rest of Asia Pacific Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
TABLE 81 Rest of Asia Pacific Cluster Headache Market by Type, 2018 - 2021, USD Million
TABLE 82 Rest of Asia Pacific Cluster Headache Market by Type, 2022 - 2028, USD Million
TABLE 83 Rest of Asia Pacific Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
TABLE 84 Rest of Asia Pacific Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
TABLE 85 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 86 Key Information – Novartis AG
TABLE 87 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 88 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 89 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 90 Key Information – Pfizer, Inc.
TABLE 91 key information – Fresenius SE & Co. KGaA
TABLE 92 Key Information – Eli Lilly And Company
TABLE 93 Key Information – Grünenthal GmbH
TABLE 94 Key Information – Arrotex Pharmaceuticals Pty Limited
List of Figures
FIG 1 Methodology for the research